166 related articles for article (PubMed ID: 15062597)
1. Chemotherapy-induced lung disease.
Limper AH
Clin Chest Med; 2004 Mar; 25(1):53-64. PubMed ID: 15062597
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drug-induced lung disease.
Sostman HD; Matthay RA; Putman CE
Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
4. Review: diagnosis of chemotherapy lung.
Sostman HD; Putman CE; Gamsu G
AJR Am J Roentgenol; 1981 Jan; 136(1):33-40. PubMed ID: 6161531
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity of antineoplastic therapy.
Kreisman H; Wolkove N
Semin Oncol; 1992 Oct; 19(5):508-20. PubMed ID: 1411649
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary effects of cytotoxic agents other than bleomycin.
Twohig KJ; Matthay RA
Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary accidents following treatments with immunodepressive agents].
Coury C; Saltiel JC
Rev Prat; 1972 Jan; 22(3):319-28. PubMed ID: 5029700
[No Abstract] [Full Text] [Related]
9. Ambroxol and pulmonary toxicity induced by antineoplastic drugs.
Luisetti M; Peona V; Salmona M; Pagnoni AM; Villani F; Knerich R; Genghini M; Abbà L; Pozzi E
Int J Clin Pharmacol Res; 1986; 6(2):129-36. PubMed ID: 2424848
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced lung disease.
Whitcomb ME
Chest; 1973 Mar; 63(3):418-22. PubMed ID: 4120558
[No Abstract] [Full Text] [Related]
11. Drug-induced pulmonary disease.
Rosenow EC; Limper AH
Semin Respir Infect; 1995 Jun; 10(2):86-95. PubMed ID: 7569403
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory pathology of immunosuppressive drugs. History, classification and clinical study].
Coury C; Saltiel JC
Rev Tuberc Pneumol (Paris); 1972; 36(5):743-61. PubMed ID: 4662344
[No Abstract] [Full Text] [Related]
13. [Pulmonary changes caused by cytostatic drugs].
Akoun G; Milleron B; Mayaud C
Ann Med Interne (Paris); 1985; 136(8):671-6. PubMed ID: 3914227
[TBL] [Abstract][Full Text] [Related]
14. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
[TBL] [Abstract][Full Text] [Related]
15. [Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
Dumortier J; Villarejo J; Lapalus MG; Vochelle V; Beatrix O; Scoazec JY; Lombard-Bohas C
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):347-8. PubMed ID: 12700527
[No Abstract] [Full Text] [Related]
16. Pulmonary complications of cytostatic medication.
Meinesz D; Seldenrath JJ
Radiol Clin Biol; 1973; 42(2):175-6. PubMed ID: 4124586
[No Abstract] [Full Text] [Related]
17. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
Real E; Roca MJ; Viñuales A; Pastor E; Grau E
Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
[No Abstract] [Full Text] [Related]
18. Acute bleomycin lung.
Perez-Guerra F; Harkleroad LE; Walsh RE; Costanzi JJ
Am Rev Respir Dis; 1972 Dec; 106(6):909-13. PubMed ID: 4118373
[No Abstract] [Full Text] [Related]
19. The spectrum of drug-induced pulmonary disease.
Rosenow EC
Ann Intern Med; 1972 Dec; 77(6):977-91. PubMed ID: 4118760
[No Abstract] [Full Text] [Related]
20. Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin.
De A; Guryev I; LaRiviere A; Kato R; Wee CP; Mascarenhas L; Keens TG; Venkatramani R
Pediatr Blood Cancer; 2014 Sep; 61(9):1679-84. PubMed ID: 24789770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
